Guardant Health, Inc. (GH) Earnings Call Analysis
NASDAQ · Healthcare · Diagnostics & Research
Earnings Reports
-
Gardent Health (GH) Q2 2026: Oncology Test Volume Jumps 63% as SHIELD Coverage Expands
July 31, 2026
-
Garden Health (GH) Q1 2026: Screening Gross Margin Triples to 56% as Shield Volumes Accelerate
May 08, 2026
-
Guardant Health (GH) Q3 2025: Oncology Volumes Surge 40% as SHIELD Run Rate Hits $100M
October 29, 2025
-
Garden Health (GH) Q2 2025: SHIELD Gross Margin Jumps to 48% as Screening Scale Accelerates
July 30, 2025
-
Garden Health (GH) Q1 2025: Oncology Volume Surges 25% as Reveal and SHIELD Turn Gross Margin Positive
July 04, 2025